Research ArticleArticle
Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms
David V. Erbe, Suyue Wang, Yan-Ling Zhang, Kimberly Harding, Leslie Kung, May Tam, Leslie Stolz, Yuzhe Xing, Sarah Furey, Ariful Qadri, Lori D. Klaman and James F. Tobin
Molecular Pharmacology January 2005, 67 (1) 69-77; DOI: https://doi.org/10.1124/mol.104.005553
David V. Erbe
Suyue Wang
Yan-Ling Zhang
Kimberly Harding
Leslie Kung
May Tam
Leslie Stolz
Yuzhe Xing
Sarah Furey
Ariful Qadri
Lori D. Klaman
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms
David V. Erbe, Suyue Wang, Yan-Ling Zhang, Kimberly Harding, Leslie Kung, May Tam, Leslie Stolz, Yuzhe Xing, Sarah Furey, Ariful Qadri, Lori D. Klaman and James F. Tobin
Molecular Pharmacology January 1, 2005, 67 (1) 69-77; DOI: https://doi.org/10.1124/mol.104.005553
Research ArticleArticle
Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms
David V. Erbe, Suyue Wang, Yan-Ling Zhang, Kimberly Harding, Leslie Kung, May Tam, Leslie Stolz, Yuzhe Xing, Sarah Furey, Ariful Qadri, Lori D. Klaman and James F. Tobin
Molecular Pharmacology January 1, 2005, 67 (1) 69-77; DOI: https://doi.org/10.1124/mol.104.005553
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement